Latest Insider Transactions at Volitionrx LTD (VNRX)
This section provides a real-time view of insider transactions for Volitionrx LTD (VNRX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of VOLITIONRX LTD to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of VOLITIONRX LTD's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 17
2025
|
Cameron John Reynolds President and CEO |
BUY
Open market or private purchase
|
Direct |
20,000
+0.78%
|
$0
$0.35 P/Share
|
|
Nov 01
2025
|
Gael Forterre Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,753
-1.13%
|
$0
$0.43 P/Share
|
|
Nov 01
2025
|
Salvatore Thomas Butera CEO - Volition Veterinary |
SELL
Payment of exercise price or tax liability
|
Direct |
4,648
-1.42%
|
$0
$0.43 P/Share
|
|
Nov 01
2025
|
Rodney Gerard Rootsaert Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
3,197
-2.28%
|
$0
$0.43 P/Share
|
|
Nov 01
2025
|
Nicholas Plummer GC - Volition Diagnostics |
SELL
Payment of exercise price or tax liability
|
Direct |
5,647
-2.83%
|
$0
$0.43 P/Share
|
|
Nov 01
2025
|
Andrew Retter Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,588
-3.04%
|
$0
$0.43 P/Share
|
|
Oct 14
2025
|
Timothy I Still |
BUY
Open market or private purchase
|
Direct |
48,076
+3.04%
|
$0
$0.51 P/Share
|
|
Oct 14
2025
|
Guy Archibald Innes |
BUY
Open market or private purchase
|
Direct |
96,153
+8.3%
|
$0
$0.51 P/Share
|
|
Oct 14
2025
|
Cameron John Reynolds President and CEO |
BUY
Open market or private purchase
|
Direct |
110,000
+4.16%
|
$0
$0.51 P/Share
|
|
Oct 04
2025
|
Jacob Vincent Micallef Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,850
-1.47%
|
$0
$0.65 P/Share
|
|
Oct 04
2025
|
Michel Gaetan Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
12,333
-4.58%
|
$0
$0.65 P/Share
|
|
Oct 04
2025
|
Nicholas Plummer GC - Volition Diagnostics |
SELL
Payment of exercise price or tax liability
|
Direct |
8,146
-3.92%
|
$0
$0.65 P/Share
|
|
Oct 04
2025
|
Gael Forterre Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,389
-3.35%
|
$0
$0.65 P/Share
|
|
Oct 04
2025
|
Rodney Gerard Rootsaert Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
4,620
-3.18%
|
$0
$0.65 P/Share
|
|
Oct 04
2025
|
Salvatore Thomas Butera CEO - Volition Veterinary |
SELL
Payment of exercise price or tax liability
|
Direct |
5,834
-1.76%
|
$0
$0.65 P/Share
|
|
Oct 04
2025
|
Ann Louise Batchelor Group Chief Marketing Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,110
-3.96%
|
$0
$0.65 P/Share
|
|
Sep 28
2025
|
Gael Forterre Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,503
-3.31%
|
$0
$0.6 P/Share
|
|
Sep 28
2025
|
Michel Gaetan Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
11,362
-2.99%
|
$0
$0.6 P/Share
|
|
Sep 28
2025
|
Ann Louise Batchelor Group Chief Marketing Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,604
-3.51%
|
$0
$0.6 P/Share
|
|
Sep 28
2025
|
Jacob Vincent Micallef Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,568
-1.38%
|
$0
$0.6 P/Share
|
|
Sep 28
2025
|
Salvatore Thomas Butera CEO - Volition Veterinary |
SELL
Payment of exercise price or tax liability
|
Direct |
5,230
-1.55%
|
$0
$0.6 P/Share
|
|
Sep 28
2025
|
Rodney Gerard Rootsaert Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
4,158
-2.79%
|
$0
$0.6 P/Share
|
|
Sep 12
2025
|
Cameron John Reynolds President and CEO |
BUY
Open market or private purchase
|
Direct |
15,000
+0.57%
|
$0
$0.66 P/Share
|
|
Aug 15
2025
|
Gael Forterre Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,727
+5.52%
|
-
|
|
Aug 15
2025
|
Jasmine Kway CEO - Singapore Volition |
BUY
Grant, award, or other acquisition
|
Direct |
12,507
+5.79%
|
-
|
|
Aug 15
2025
|
Kim Nguyen |
BUY
Grant, award, or other acquisition
|
Direct |
17,424
+13.08%
|
-
|
|
Aug 15
2025
|
Ethel Rubin |
BUY
Grant, award, or other acquisition
|
Direct |
17,424
+21.68%
|
-
|
|
Aug 15
2025
|
Nicholas Plummer GC - Volition Diagnostics |
BUY
Grant, award, or other acquisition
|
Direct |
24,031
+10.36%
|
-
|
|
Aug 15
2025
|
Andrew Retter Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
19,524
+11.44%
|
-
|
|
Aug 15
2025
|
Salvatore Thomas Butera CEO - Volition Veterinary |
BUY
Grant, award, or other acquisition
|
Direct |
33,991
+9.15%
|
-
|
|
Aug 15
2025
|
Rodney Gerard Rootsaert Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
15,223
+9.26%
|
-
|
|
Aug 15
2025
|
Ann Louise Batchelor Group Chief Marketing Officer |
BUY
Grant, award, or other acquisition
|
Direct |
27,400
+14.63%
|
-
|
|
Aug 15
2025
|
Terig Hughes Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
26,143
+4.67%
|
-
|
|
Aug 05
2025
|
Cameron John Reynolds President and CEO |
BUY
Open market or private purchase
|
Direct |
78,125
+2.91%
|
$0
$0.64 P/Share
|
|
Aug 05
2025
|
Guy Archibald Innes |
BUY
Open market or private purchase
|
Direct |
78,125
+7.48%
|
$0
$0.64 P/Share
|
|
Aug 01
2025
|
Rodney Gerard Rootsaert Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
4,279
-3.09%
|
$0
$0.64 P/Share
|
|
Aug 01
2025
|
Gael Forterre Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,766
-1.73%
|
$0
$0.64 P/Share
|
|
Aug 01
2025
|
Nicholas Plummer GC - Volition Diagnostics |
SELL
Payment of exercise price or tax liability
|
Direct |
4,451
-2.36%
|
$0
$0.64 P/Share
|
|
Aug 01
2025
|
Ann Louise Batchelor Group Chief Marketing Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,620
-6.11%
|
$0
$0.64 P/Share
|
|
Aug 01
2025
|
Andrew Retter Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,142
-4.46%
|
$0
$0.64 P/Share
|
|
Aug 01
2025
|
Salvatore Thomas Butera CEO - Volition Veterinary |
SELL
Payment of exercise price or tax liability
|
Direct |
6,393
-2.06%
|
$0
$0.64 P/Share
|
|
Jul 24
2025
|
Cameron John Reynolds President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
200,000
+7.32%
|
-
|
|
Jul 24
2025
|
Terig Hughes Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+16.46%
|
-
|
|
Jul 01
2025
|
Andrew Retter Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,401
-3.1%
|
$0
$0.77 P/Share
|
|
Jul 01
2025
|
Salvatore Thomas Butera CEO - Volition Veterinary |
SELL
Payment of exercise price or tax liability
|
Direct |
4,462
-1.42%
|
$0
$0.77 P/Share
|
|
Jul 01
2025
|
Ann Louise Batchelor Group Chief Marketing Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,177
-4.19%
|
$0
$0.77 P/Share
|
|
Jul 01
2025
|
Rodney Gerard Rootsaert Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
3,066
-2.17%
|
$0
$0.77 P/Share
|
|
Jul 01
2025
|
Nicholas Plummer GC - Volition Diagnostics |
SELL
Payment of exercise price or tax liability
|
Direct |
5,417
-2.8%
|
$0
$0.77 P/Share
|
|
Jun 12
2025
|
Cameron John Reynolds President and CEO |
BUY
Open market or private purchase
|
Direct |
12,500
+0.53%
|
$0
$0.59 P/Share
|
|
Jun 03
2025
|
Guy Archibald Innes |
BUY
Open market or private purchase
|
Direct |
20,000
+2.2%
|
$0
$0.54 P/Share
|